The naturally “looped” structure of blood cells’ genetic material is changing in T cell leukemia.

An 18 percent drop in deaths from melanoma may relate to the introduction of new immunotherapies.

A study finds that cells exposed to bacteria release tiny, protein-coated packages called exosomes.

This study compares overdose risk among two patient populations in treatment across an entire state.

A new study examines the increase in popularity among adults age 65 and older in the United States.

The new evidence-based recommendations set best practices.

Study reveals new biology behind, and drug targets against, endometrial cancer.

The medical oncologist discusses milestones in the development of immunotherapies for melanoma.

Examining resected tumors reveals a lung microbiota signature associated with a poor prognosis.

The host–microbe relationship plays a key role in this stubborn infection.